Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Verastem (VSTM) stock receives a "Buy" rating, driven by progress in KRAS G12D-targeted therapies and multiple 2026 catalysts ...
In this study, researchers aimed to characterize the mutational landscape of the tumors of domestic cats to determine whether similarities to humans could translate to the clinic.
The researchers found higher ATF4 levels in tumors from older subjects, both in mice and in human patients. Elevated ATF4 was ...
For oncologists navigating the rapidly evolving landscape of renal cell carcinoma (RCC), the data presented at the 2026 ASCO ...
When Dan Hannon, 72, received guidance to have part of a lung taken out whether nodules were cancerous or not, he wanted a ...
Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program ...
TACTI-004 planned ~756 patients across >150 sites and enrolled 378 by February 2026, including squamous and nonsquamous NSCLC irrespective of PD-L1 status. Randomization compared eftilagimod alfa plus ...
KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, has discovered how cancer cells can ...
6d
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests
Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results